Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.
Amsterdam, Noord-Holland, The Netherlands Related Funds
| Fund Name | Location |
| Amnis Ventures | Houston, Texas, United States |
| ArchVentures SA | Faro, Faro, Portugal |
| Arena Alpha | - |
| Binux Capital | California, Saratoga, United States |
| Blockchange Ventures | New York, New York, United States |
| CD Capital | England, London, United Kingdom |
| Deerfield Capital Management | Illinois, Rosamond, United States |
| DS Investment Management Co.,Ltd | Seoul, Seoul-t'ukpyolsi, South Korea |
| eGuardian | Central Region, Singapore, Singapore |
| Hongji Bike | China, Hangzhou, Zhejiang |
| NewDo Venture | California, Palo Alto, United States |
| Orchestra Medical Ventures | New York, New York, United States |
| Science Foundation Ireland | County Dublin, Dublin, Ireland |
| SolarEdge Technologies | Herzliya, Israel, Tel Aviv |
| Tinicum | New York, New York, United States |
| W8 Ventures | England, London, United Kingdom |
| WuXi Biologics | Anhui, China, Wuxi |
| Xuhui Venture Capital | China, Shanghai |
| Zhoushan Hongyi Guquan Touzi | China, Dinghai, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
LaNova Medicines | 28 Jun 2022 | Shanghai, Shanghai, China | |||
Lukka | $110M | 14 Jan 2022 | New York, New York, United States | ||
SEBA Bank | $119M | 12 Jan 2022 | Zug, Switzerland | ||
Animoca Brands | $65M | 20 Oct 2021 | Hong Kong Island, Hong Kong, China | ||
LeapXpert | $9M | 13 Oct 2021 | Hong Kong Island, Hong Kong, China | ||
Codingal | $1M | 01 Sep 2021 | Bengaluru, Karnataka, India | ||
Dingdang Kuaiyao | $220M | 08 Jun 2021 | Dongcheng District, Beijing, China | ||
Broncus Technologies | 28 Jan 2021 | Mountain View, California, United States | |||
CANbridge Pharmaceuticals | $43M | 01 Dec 2020 | Beijing |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 
Get matched with relevant funds
